The clone Escherichia coli O25 ST131, typically producing extended-spectrum beta-lactamases (ESBLs), has spread globally and became the dominant type among extraintestinal isolates at many parts of the world. However, the reasons behind the emergence and success of this clone are only partially understood. We compared the core type genes by PCR of ESBL-producing and ESBLnonproducing strains isolated from urinary tract infections in the United Arab Emirates and found a surprisingly high frequency of the K-12 core type (44.6%) among members of the former group, while in the latter one, it was as low (3.7%), as reported earlier. The high figure was almost entirely attributable to the presence of members of the clone O25 ST131 among ESBL producers. Strains from the same clone isolated in Europe also carried the K-12 core type genes. Sequencing the entire core operon of an O25 ST131 isolate revealed a high level of similarity to known K-12 core gene sequences and an almost complete identity with a recently sequenced non-O25 ST131 fecal isolate. The exact chemical structure and whether and how this unusual core type contributed to the sudden emergence of ST131 require further investigations.
Introduction
In Escherichia coli, the core oligosaccharide (OS) part of the lipopolysaccharide (LPS) molecule occurs in fivedifferent types: R1-4 and K-12, respectively (Muller-Loennies et al., 2007) . The core has a crucial role in maintaining the structure of the cell wall, although to what extent and how its specific type affects the colonizing capacity or the virulence of a pathogen remains to be elucidated. Nevertheless, earlier studies consistently found a highly disproportional distribution of these core types among commensal and clinical E. coli isolates (Gibb et al., 1992; Appelmelk et al., 1994; Amor et al., 2000; Gibbs et al., 2004) . Among strains recovered from extraintestinal infections, the frequency of R1 core type reached 61.0-81.0%, while that of the K-12 type was found the least or the second least common (2.2-5.6%) (Gibb et al., 1992; Appelmelk et al., 1994; Amor et al., 2000) . These frequencies were well reflected by the distribution of core-type-specific antibodies in the population (Gibbs et al., 2004) .
In the past decade, the spread of extended-spectrum beta-lactamase (ESBL)-producing E. coli strains considerably altered the epidemiology and treatment options of extraintestinal infections (Woodford et al., 2011; Van der Bij et al., 2012) . A significant percentage of these isolates belong to a limited number of clones, some considerably differing in their panel of virulence factors from those described earlier (Totsika et al., 2011; Van der Bij et al., 2012) . As no data were available on the core types of these fast spreading clones, we investigated whether the increased frequency of ESBL-producing organism among urinary tract isolates has had any impact on the core type distribution of E. coli isolates.
Materials and methods

Strain collection and phenotypic microbiological methods
All nonrepeat, clinically significant, ESBL-producing E. coli (n = 121) strains isolated from urine samples in Tawam Hospital, Al Ain, United Arab Emirates, between May 2008 and April 2009 were studied and compared to a pool of matching number of ESBLnonproducing urine isolates (n = 109) collected during the same period of time. From our strain collection, 10 representatives of the E. coli ST131 clone isolated in Hungary from urinary tract infection (UTI) (5 strains) and from bloodstream infection (BSI) (five strains) in 2008 and 2009 , respectively, were also tested. Isolates were stored in glycerol at À80°C. Strains were identified, and the initial antibiotic susceptibility test was carried out by the VITEK 2 automated system (Biomérieux). ESBL production was phenotypically confirmed according to the CLSI standards (CLSI, 2010) using ceftazidime and cefotaxime discs with and without clavulanic acid. Expression of the O25 cell wall antigen was determined by slide agglutination using specific antibodies purchased from the MAST Group Ltd, Boottle, UK, according to the manufacturer's instructions.
Molecular typing of the isolates
The phylogenetic type of isolates was established according to (Clermont et al. (2000) . Macrorestriction analysis of the strains was carried out by pulsed field gel electrophoresis (PFGE) using a CHEF-Mapper system (BioRad, Hercules, CA) subsequent to the digestion of the genom by XbaI (Gautom, 1997) . The macrorestriction patterns were compared according to Dice similarity index (1-1% tolerance interval) using the GELCOMPARE II software (Applied Maths, Sint-Martens-Latem, Belgium). A pulsotype was arbitrarily defined as a cluster of strains exhibiting macrorestriction banding patterns with ! 80% similarity. Twenty-four selected isolates representing all pulsotypes were also submitted to multilocus sequence typing (MLST) (Wirth et al., 2006) . The MLST type of strain SE15 was established in silico, based on published sequences [GenBank No. AP009378 (Toh et al., 2010) ].
The core type of the isolates was determined by PCR using primers targeting genes in the core operon and specific the R1-4 and K-12 core types, respectively (Amor et al., 2000) . All strains were also subjected to a PCR detecting the rfb O25b gene specific to the 25b O serogroup (Blanco et al., 2009 ).
Sequencing of the waa locus
Genomic DNA of strain 81009 was purified with Wizard Genomic DNA purification kit (Promega). About 1-to 3-kb overlapping fragments between genes kbl and coaD were amplified with KlenTaq LA DNA Polymerase Mix (Sigma), visualized in 1% agarose gels, purified with QIAquick Gel Extraction Kit (Qiagen), and sequenced at Eurofins MWG Operon (Germany). Sequences were assembled with CLC Main Workbench 6.0.2.
Results and discussion
Comparing the distribution of core-specific genes in groups of ESBL-producing (n = 121) and ESBL-nonproducing (n = 109) urinary E. coli isolates in the former group, we detected a surprisingly high rate (44.6%) of positivity with a K-12 core-specific PCR (Table 1) . This considerably exceeded the rate reported by previous studies (Gibb et al., 1992; Appelmelk et al., 1994; Amor et al., 2000; Gibbs et al., 2004) . As the core type distribution among non-ESBL-producing strains (3.7%) was similar to those found earlier (Table 1) , and as the production of ESBL is, at least partly, a clonal phenomenon (Woodford et al., 2011) , the possible clustering of the 58 K-12 core PCR-positive isolates was investigated. We found that 54 of these strains (93.1%) carried the rfb O25b gene with the O25 serogroup also confirmed by slide agglutination. All strains belonged to the B2 phylogenetic group. All isolates, except two, were ESBL-producing strains. Fifty-two of the 54 K-12 core and rfb O25b -positive strains were typable by PFGE exhibiting 18 pulsotypes (10 clusters with 2-11 members and 8 singletons) (Fig. 1) . Twenty-four selected isolates representing all pulsotypes were submitted to MLST and found to belong to the rapidly spreading, often multidrug resistant ST131 clone (Fig. 1) .
To rule out that the presence of the K-12 core-specific genes was restricted to Emirati UTI isolates of the O25 ST131 group, ten independent representatives of this clone isolated in Hungary from UTI (five strains) and BSI (five strains) in 2008 and 2009, respectively, were also tested. Importantly, all these strains were also positive with the K-12 core-specific PCR (Fig. 1) .
Next, we determined the DNA sequence of the entire waa locus (Heinrichs et al., 1998) of one of the O25-ST131 isolates from our collection (#81009). The resulting > 16-kb sequence (GenBank JQ241150) covered the 15 K-12 core genes (Muller-Loennies et al., 2007) between the kbl and the coaD genes flanking the waa locus. As expected, based on the PCR results, individual gene sequences displayed extensive homology to their respective homologues in the prototype K-12 commensal strain, MG1655 (Table 2) . Comparison of the deduced amino acid sequences of the various Waa proteins of the ST131 O25 strain #81009 revealed ! 90% identities with their counterparts in MG1655 with the exception of WaaQ, exhibiting a 71% homology, only (Table 2 ). This enzyme of strain #81009, however, was 99% identical to its counterparts found in strains with core types R1, R3, and R4 Fig. 1 . Pulsotypes of phylogenetic group B2, rfb O25 , and K-12 core PCR-positive isolates. *All strains except 306-0838 and 270-2067 were ESBL producers. MLST -results are shown for all strains typed by MLST. Origin -HUN UTI: strain isolated from UTI in Hungary. HUN BSI: strain isolated from blood stream infection in Hungary. Strains without marks are all strains isolated from UTIs in Al Ain, UAE. Note: The two nontypable isolates, one of them also identified as ST131, are not shown. (Table 2) , while the WaaQ protein encoded by the MG1655 allele was identical to that of a representative R2 strain, F632. Because the function of this protein as a heptosyltransferase is completely conserved in all core types (Muller-Loennies et al., 2007), we surmise that this sequence variation is unlikely to have functional consequences.
An almost 100% identity (except two nucleotide differences resulting in a single amino acid mismatch in WaaB) of the entire waa locus of the strain #81009 was found with that of a commensal fecal isolate SE15 of the B2 phylogenetic group (Toh et al., 2010) (Table 2) . Importantly, although SE15 reportedly expressed serotype O150: H5, its sequence type, as revealed by the in silico MLST analysis from the published sequence, was ST131. This is the first report on the complete core operon sequence of an O25 ST131 isolate. Recently, two groups reported on the total genome sequences of O25 ST131 (Avasthi et al., 2011; Totsika et al., 2011) and deposited it in GenBank; however, none of them contained the complete waa cluster. In strain EC958 (Totsika et al., 2011) , the locus annotated as 'O-antigen 2' and available as parts of two nonoverlapping contigs (GenBank CAFL01000107.1 and CAFL01000108.1) contained the waa genes, which, with the exception of a 293-bp-long fragment missing from the waaR gene, exhibited 100% identity with the waa operon of strain #81009.
Similarly, the sequences of the waaA, waaQ, waaG, waaP, waaC, waaF, and waaD genes of another O25 ST131 strain (NA114) (Avasthi et al., 2011) were 100% identical to the respective genes of our isolate. However, a large fragment corresponding to the sequence between 4715-12806 bp of our ST131 isolate (GenBank JQ241150) was missing from the sequence available in the database. As this represents a considerable part of the waa operon, including the complete waaB, waaI, waaR, waaY, waaZ, waaU genes and parts of waaS and waaL genes, an extensive comparison between the waa operons of stains #81009 and NA114 was not possible.
The high level of similarity in the genetic background of core synthesis of the ST131 strains to that of strain MG1655 suggests that it is also likely to be similar to the known structure of the K-12 core, but definitely different from those of the other E. coli LPS core types (MullerLoennies et al., 2007) . However, it remains to be elucidated whether the 4-10% nonidentity of the LPS synthesis enzymes of the tested ST131 strain and the prototype K-12 MG1655 strain is reflected in any differences in the chemical composition of the outer core. It is interesting to note that an unusual glycoform composition of the K-12 core was recently described in a strain isolated from bovine mastitis, although no sequence of the encoding locus has been made available for comparison (Duda et al., 2011) .
In light of the previously found low frequency of the K-12 core type among E. coli strains, it is intriguing to contemplate why the highly successful ESBL-producing ST131 clone carries this type seldom harbored by pathogenic E. coli (Amor et al., 2000) . Unlike the strain MG1655, that is, a phylogenetic group A strains characterized with limited virulence, members of the ST131 clone, and in general, those of the B2 phylogenetic group are characterized with considerable extraintestinal pathogenic potential (Totsika et al., 2011; Van der Bij et al., 2012) .
Although the role of anticore antibodies in interfering with bacterial colonization is still speculative, a hypothesis was recently proposed regarding their contribution to prevent mucosal infections, such as the one caused by E. coli O157 (Currie et al., 2001) . Further investigations should clarify whether the low anti-K12 core antibody titers found in the population earlier (Gibbs et al., 2004) could have contributed to a permissive environment allowing the rapid spread of the K-12 core-containing strains, such as the members of ST131 clone, in the gut and in extraintestinal niches.
As most of the epidemiological studies revealing the frequency of various core types and core-specific antibodies were conducted prior the emergence of the ST131 clone (Gibb et al., 1992; Appelmelk et al., 1994; Amor et al., 2000; Gibbs et al., 2004) , it remains to be seen whether its recent spread has had any effect on the prevalence of antibodies with the respective specificities. As our clinical isolates were preselected according to ESBL production, these data do not allow drawing a direct conclusion regarding the current frequency of strains with a K-12 core type in UTI. However, as the incidence of third-generation cephalosporin resistance among local E. coli isolates during the period of strain collection was 23.7% (Al-Kaabi et al., 2011) and because 44.6% of the ESBL-producing isolates were positive with the K-12 core PCR, a considerable increase in K-12-type E. coli compared to the figures found earlier, that is, 2.2-5.6% (Gibb et al., 1992; Appelmelk et al., 1994; Amor et al., 2000) , can be anticipated. The rapid spread of the ST131 clone and the fact that it still keeps evolving by acquiring genes as bla KPC-2 or bla NDM-1 (Morris et al., 2011; Peirano et al., 2011) further extending its antibiotic resistance emphasize the need to identify the factors responsible for its fitness and virulence. Revealing the genetic background for its LPS core OS synthesis may contribute to finding some of the answers and may even lead to the development of preventive and curative interventions. K-12 core type synthesis genes of Escherichia coli O25 ST131
